Camlin Fine Sciences Ltd Share Price – NSE  / BSE

Chemicals, Small Cap

Camlin Fine Sciences announced that the 33th Annual General Meeting(AGM) of the company will be held on 11 August 2026.

Net profit of Camlin Fine Sciences reported to Rs 88.20 crore in the quarter ended March 2026 as against net loss of Rs 0.72 crore during the previous quarter ended March 2025. Sales declined 1.57% to Rs 424.81 crore in the quarter ended March 2026 as against Rs 431.58 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 27.63 crore in the year ended March 2026 as against net loss of Rs 139.05 crore during the previous year ended March 2025. Sales rose 5.81% to Rs 1723.31 crore in the year ended March 2026 as against Rs 1628.69 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

The board of Camlin Fine Sciences at its meeting held on 26 May 2026 has approved the appointment of Pankaj Pandey as Chief Financial Officer (CFO) and Key Managerial Personnel of the Company, effective 18 August 2026. Further, the board approved the re-designation of Santosh Parab, currently Chief Financial Officer, as President ? Strategy and Global CFO, effective 18 August 2026.

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 26 May 2026.